BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Čermáková M, Pelantová H, Neprašová B, Šedivá B, Maletínská L, Kuneš J, Tomášová P, Železná B, Kuzma M. Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats. J Proteome Res 2019;18:1735-50. [PMID: 30810318 DOI: 10.1021/acs.jproteome.8b00964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng Y, Huang C, Su J, Pan C, Ke C. Identification of biomarkers for essential hypertension based on metabolomics. Nutrition, Metabolism and Cardiovascular Diseases 2021;31:382-95. [DOI: 10.1016/j.numecd.2020.11.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pražienková V, Popelová A, Kuneš J, Maletínská L. Prolactin-Releasing Peptide: Physiological and Pharmacological Properties. Int J Mol Sci 2019;20:E5297. [PMID: 31653061 DOI: 10.3390/ijms20215297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
3 Mráziková L, Hojná S, Pačesová A, Hrubá L, Strnadová V, Neprašová B, Železná B, Kuneš J, Maletínská L. Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances. Nutr Diabetes 2022;12:26. [PMID: 35589696 DOI: 10.1038/s41387-022-00205-3] [Reference Citation Analysis]
4 Mráziková L, Neprašová B, Mengr A, Popelová A, Strnadová V, Holá L, Železná B, Kuneš J, Maletínská L. Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models. Front Pharmacol 2021;12:779962. [PMID: 34867411 DOI: 10.3389/fphar.2021.779962] [Reference Citation Analysis]